Physician profile
Deborah August
NPI 1801871504
$1,280.63
in general payments reported to CMS, 2019-2025
17 companies · $13.48 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $943 · 2020: $296 · 2024: $28.44 · 2025: $13.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $41.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $41.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $238.51 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $179.18 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $154.40 | 2019-2020 | |
| Lilly USA, LLC | $108.56 | 2019-2020 | |
| Tesaro, INC. | $82.36 | 2019 | |
| Glaxosmithkline, LLC. | $71.15 | 2020 | |
| Clovis Oncology, INC. | $67.19 | 2019 | |
| Celgene Corporation | $64.99 | 2019 | |
| Amgen INC. | $60.99 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $60.44 | 2020 | |
| Merck Sharp & Dohme LLC | $45.34 | 2019 | |
| Abbvie INC. | $44.07 | 2019 | |
| Janssen Biotech, INC. | $33.86 | 2020 | |
| Adaptive Biotechnologies Corporation | $28.44 | 2024 | Clonoseq |
| Takeda Pharmaceuticals U.S.A., INC. | $16.46 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bio-Rad Laboratories, INC. | $13.48 | 2025 | Bio-Rad |
| Bayer Healthcare Pharmaceuticals INC. | $11.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah August listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.